Literature DB >> 1404592

Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein.

R Schreck1, R Grassmann, B Fleckenstein, P A Baeuerle.   

Abstract

Oxygen radical scavengers, such as dithiocarbamates and cysteine derivatives, inhibit activation of the ubiquitous transcription factor nuclear factor kappa B (NF-kappa B) after treatment of cells with tumor necrosis factor, phorbol ester, and interleukin-1. An involvement of oxygen radicals was more directly evident from the induction of NF-kappa B by low concentrations of H2O2 and the demonstration that cells stimulated with various NF-kappa B inducers release H2O2 and superoxide. In this study, we used the antioxidant pyrrolidine dithiocarbamate (PDTC) to investigate whether the activation of NF-kappa B by the viral transactivator Tax from human T-cell leukemia virus type I also depends on the production of reactive oxygen intermediates. The Tax-induced activation of the DNA-binding activity of NF-kappa B in Jurkat T cells was potently suppressed by micromolar concentrations of PDTC. Within the same concentration range, PDTC and two other dithiocarbamates also strongly interfered with transactivation of the long terminal repeat (LTR) of human immunodeficiency virus type 1 by Tax but had no effect on transactivation of the same LTR by Tat. Transactivation of the human T-cell leukemia virus type I LTR by Tax was also barely influenced. Tax seems to activate NF-kappa B by a mechanism shared with all other inducers of NF-kappa B tested so far. It appears that one of the pleiotropic activities of Tax leads to an enhanced production of oxygen radicals that are required for activation of NF-kappa B.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1404592      PMCID: PMC240120     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-I Tax proteins is mediated by different cis-acting sequences.

Authors:  K Zimmermann; M Dobrovnik; C Ballaun; D Bevec; J Hauber; E Böhnlein
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

2.  Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus.

Authors:  B J Biegalke; A P Geballe
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

Review 3.  The biochemistry of AIDS.

Authors:  Y N Vaishnav; F Wong-Staal
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

4.  Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study.

Authors:  E M Hersh; G Brewton; D Abrams; J Bartlett; J Galpin; P Gill; R Gorter; M Gottlieb; J J Jonikas; S Landesman
Journal:  JAMA       Date:  1991-03-27       Impact factor: 56.272

Review 5.  Therapeutic properties of sodium diethyldithiocarbamate: its role as an inhibitor in the progression of AIDS.

Authors:  F W Sunderman
Journal:  Ann Clin Lab Sci       Date:  1991 Jan-Feb       Impact factor: 1.256

6.  Isolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I.

Authors:  A Tsujimoto; H Nyunoya; T Morita; T Sato; K Shimotohno
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.

Authors:  Y Iwakura; M Tosu; E Yoshida; M Takiguchi; K Sato; I Kitajima; K Nishioka; K Yamamoto; T Takeda; M Hatanaka
Journal:  Science       Date:  1991-08-30       Impact factor: 47.728

8.  Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization.

Authors:  M Meyer; W H Caselmann; V Schlüter; R Schreck; P H Hofschneider; P A Baeuerle
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

9.  A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene.

Authors:  S K Hansen; C Nerlov; U Zabel; P Verde; M Johnsen; P A Baeuerle; F Blasi
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

10.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.

Authors:  R Schreck; B Meier; D N Männel; W Dröge; P A Baeuerle
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  27 in total

1.  Transcriptional activation of the vascular cell adhesion molecule-1 gene in T lymphocytes expressing human T-cell leukemia virus type 1 Tax protein.

Authors:  H Valentin; I Lemasson; S Hamaia; H Cassé; S König; C Devaux; L Gazzolo
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.

Authors:  Francesca Cerimele; Traci Battle; Rebecca Lynch; David A Frank; Emma Murad; Cynthia Cohen; Nada Macaron; John Sixbey; Kenneth Smith; Randolph S Watnick; Aristidis Eliopoulos; Bahig Shehata; Jack L Arbiser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

3.  A cooperative interaction of human T-cell leukemia virus type 1 Tax with the p21 cyclin-dependent kinase inhibitor activates the human immunodeficiency virus type 1 enhancer.

Authors:  S F Parker; N D Perkins; S D Gitlin; G J Nabel
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Interferon gamma-induced gene expression of the novel secretory phospholipase A2 type IID in human monocyte-derived macrophages is inhibited by lipopolysaccharide.

Authors:  John Lindbom; Anders G Ljungman; Christer Tagesson
Journal:  Inflammation       Date:  2005-04       Impact factor: 4.092

5.  Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.

Authors:  T A McKinsey; J A Brockman; D C Scherer; S W Al-Murrani; P L Green; D W Ballard
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

6.  Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation.

Authors:  J A Brockman; D C Scherer; T A McKinsey; S M Hall; X Qi; W Y Lee; D W Ballard
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

7.  Antioxidant: a new role for RU-486 and related compounds.

Authors:  S Parthasarathy; A J Morales; A A Murphy
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Human T-cell lymphotropic virus type 1 Tax1 activation of NF-kappa B: involvement of the protein kinase C pathway.

Authors:  P F Lindholm; M Tamami; J Makowski; J N Brady
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway.

Authors:  P Chirillo; M Falco; P L Puri; M Artini; C Balsano; M Levrero; G Natoli
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Oxidative stress and superoxide dismutase in development, aging and gene regulation.

Authors:  R G Allen
Journal:  Age (Omaha)       Date:  1998-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.